Appendix B: Panel Roster and Financial Disclosures
Toxoplasma gondii
| Member | Institution | Financial Disclosure | |
|---|---|---|---|
| Company | Relationship | ||
| Sarita Boyd | U.S. Food and Drug Administration | None | N/A |
| Joseph Kovacs* | National Institutes of Health |
Martinas BioPharma Merck |
Research Support (paid to institution) |
| Janaki Kuruppu | National Institutes of Health | None | N/A |
| Leon Lai | MedStar Washington Hospital Center | None | N/A |
| Jose M. Miro | Hospital Clinic-IDIBAPS, University of Barcelona, Spain | None | N/A |
| Daniel Podzamczer | Fight AIDS and Infectious Disease Foundation, Hospital Germans Trias i Pujol, Badalona, Spain |
Janssen ViiV Healthcare |
Consultant |
| Gilead Sciences MSD |
Research Support (paid to institution) | ||
| Bryan R. Smith | National Institutes of Health | None | N/A |
| * Group lead Note: Members are required to update disclosures annually and to notify guideline staff of any relevant changes in status during the interim. |
|||
Download Guidelines
- Section OnlyPDF (156.41 KB)
- Full GuidelinePDF (5.47 MB)
- Tables OnlyPDF (1.01 MB)